Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2021-02-12

FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Risperdal Consta (risperidone) from Janssen Pharmaceuticals to update the product labeling, potentially adding o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Risperdal Consta (risperidone long-acting injectable)

Snippet

SUPPL AP for RISPERDAL CONSTA (RISPERIDONE)